Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital, discusses therapies and management guidelines for patients with interstitial lung ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Patients with endocrine-resistant, HER2-negative, locally advanced or metastatic breast cancer can use the treatment after ...

Harrington Hospital reduced 30-day readmissions for congestive heart failure by 50% using artificial intelligence and remote ...

National Oncology Conference began with a diverse range of poster exhibits, highlighting important initiatives in patient ...

An integrated, rule-based informatics system demonstrated its capacity to leverage electronic health records to streamline ...

The study is among the first to look at the potential impacts of clonal dynamics on patients with lower-risk myelodysplastic ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

Here are 5 key points for pre–breast screening preparation that cover the areas of risk assessment, lifestyle adjustments, ...

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.